国家药品抽检承检管理中有关问题的探讨  

Discussion on Common Problems in the Inspection Process Management of National Drug Sampling and Inspection

作　　者：王露黔 朱洪 WANG Luqian;ZHU Hong(Department of Business Management,Wuxi Center for Drug Safety Control,Wuxi 214028,China)

机构地区：[1]无锡市药品安全检验检测中心业务管理科,无锡214028

出　　处：《药学与临床研究》2023年第2期191-192,共2页Pharmaceutical and Clinical Research

摘　　要：根据2020~2021年无锡药检中心国家药品抽检承检开展情况,以及与其他承检机构的经验交流,总结承检工作中收样环节与调研工作开展过程中问题解决经验与优化策略,以提高国家药品抽检管理效率。Based on the practice of national drug sampling and inspection in Wuxi Center for Drug Safety Control from 2020 to 2021,as well as the experience exchanged with other inspection institutions,problem solving and optimization strategies in sample collection and investigation were summarized,so as to improve the efficiency of national drug sampling management.

关 键 词：国家药品抽检 收样环节 调研工作 

分 类 号：R951[医药卫生—药学]